Concomitant Hiatal Hernia Repair with Sleeve Gastrectomy: Can Gastroesophageal Reflux be alleviated?
EAES Academy. Kumar A. 07/05/22; 362970; P013
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction:
HH present in about 37-50 % of morbidly obese patients undergoing bariatric surgery and 50-70 % of the patients undergoing this surgery have symptoms of reflux. This study is to assess the effect of concomitant HHR in patients undergoing LSG with or without GERD using GERD Q questionnaire.
Methods:
It is a retrospective analysis of prospectively maintained database involving sixty-three morbidly obese patients who underwent LSG with concomitant HHR from April 2013 to September 2019. The patients were diagnosed with HH either on preoperative endoscopy or on intraoperative assessment. They were subsequently followed for use of antacids and symptoms of GERD using GERDQ questionnaire prior to surgery and at 6 months, 12 months and 24 months after surgery.
Results:
Of the 63 patients, Forty-eight patients were assessed with an average follow-up of 24 months after surgery. Around 56% of the patients had complete resolution of their preoperative reflux symptoms with significant improvement in their GERDQ scores, while 33% of the patients observed no change in their GERD Q scores. Five patients (10%) developed de novo Gastroesophageal reflux symptoms on an average follow-up of 2 years.
Conclusions:
In patients of morbid obesity with HH, concomitant HHR with LSG will lead to the improvement of the GERD and decreases the chances of de novo GERD in asymptomatic patients.
HH present in about 37-50 % of morbidly obese patients undergoing bariatric surgery and 50-70 % of the patients undergoing this surgery have symptoms of reflux. This study is to assess the effect of concomitant HHR in patients undergoing LSG with or without GERD using GERD Q questionnaire.
Methods:
It is a retrospective analysis of prospectively maintained database involving sixty-three morbidly obese patients who underwent LSG with concomitant HHR from April 2013 to September 2019. The patients were diagnosed with HH either on preoperative endoscopy or on intraoperative assessment. They were subsequently followed for use of antacids and symptoms of GERD using GERDQ questionnaire prior to surgery and at 6 months, 12 months and 24 months after surgery.
Results:
Of the 63 patients, Forty-eight patients were assessed with an average follow-up of 24 months after surgery. Around 56% of the patients had complete resolution of their preoperative reflux symptoms with significant improvement in their GERDQ scores, while 33% of the patients observed no change in their GERD Q scores. Five patients (10%) developed de novo Gastroesophageal reflux symptoms on an average follow-up of 2 years.
Conclusions:
In patients of morbid obesity with HH, concomitant HHR with LSG will lead to the improvement of the GERD and decreases the chances of de novo GERD in asymptomatic patients.
Introduction:
HH present in about 37-50 % of morbidly obese patients undergoing bariatric surgery and 50-70 % of the patients undergoing this surgery have symptoms of reflux. This study is to assess the effect of concomitant HHR in patients undergoing LSG with or without GERD using GERD Q questionnaire.
Methods:
It is a retrospective analysis of prospectively maintained database involving sixty-three morbidly obese patients who underwent LSG with concomitant HHR from April 2013 to September 2019. The patients were diagnosed with HH either on preoperative endoscopy or on intraoperative assessment. They were subsequently followed for use of antacids and symptoms of GERD using GERDQ questionnaire prior to surgery and at 6 months, 12 months and 24 months after surgery.
Results:
Of the 63 patients, Forty-eight patients were assessed with an average follow-up of 24 months after surgery. Around 56% of the patients had complete resolution of their preoperative reflux symptoms with significant improvement in their GERDQ scores, while 33% of the patients observed no change in their GERD Q scores. Five patients (10%) developed de novo Gastroesophageal reflux symptoms on an average follow-up of 2 years.
Conclusions:
In patients of morbid obesity with HH, concomitant HHR with LSG will lead to the improvement of the GERD and decreases the chances of de novo GERD in asymptomatic patients.
HH present in about 37-50 % of morbidly obese patients undergoing bariatric surgery and 50-70 % of the patients undergoing this surgery have symptoms of reflux. This study is to assess the effect of concomitant HHR in patients undergoing LSG with or without GERD using GERD Q questionnaire.
Methods:
It is a retrospective analysis of prospectively maintained database involving sixty-three morbidly obese patients who underwent LSG with concomitant HHR from April 2013 to September 2019. The patients were diagnosed with HH either on preoperative endoscopy or on intraoperative assessment. They were subsequently followed for use of antacids and symptoms of GERD using GERDQ questionnaire prior to surgery and at 6 months, 12 months and 24 months after surgery.
Results:
Of the 63 patients, Forty-eight patients were assessed with an average follow-up of 24 months after surgery. Around 56% of the patients had complete resolution of their preoperative reflux symptoms with significant improvement in their GERDQ scores, while 33% of the patients observed no change in their GERD Q scores. Five patients (10%) developed de novo Gastroesophageal reflux symptoms on an average follow-up of 2 years.
Conclusions:
In patients of morbid obesity with HH, concomitant HHR with LSG will lead to the improvement of the GERD and decreases the chances of de novo GERD in asymptomatic patients.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}